Use of Preclinical Models to Improve Treatment of Retinoblastoma
Open Access
- 25 October 2005
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 2 (10), e332
- https://doi.org/10.1371/journal.pmed.0020332
Abstract
Dyer and colleagues examine the most promising preclinical models that recapitulate the molecular, genetic, and cellular features of retinoblastoma.Keywords
This publication has 26 references indexed in Scilit:
- Retinoblastoma: Teacher of Cancer Biology and MedicinePLoS Medicine, 2005
- Topotecan Combination Chemotherapy in Two New Rodent Models of RetinoblastomaClinical Cancer Research, 2005
- Subconjunctival Carboplatin in Fibrin Sealant in the Treatment of Transgenic Murine RetinoblastomaOphthalmology, 2005
- Cancer genes and the pathways they controlNature Medicine, 2004
- Mouse models of childhood cancer of the nervous systemJournal of Clinical Pathology, 2004
- Genetic analysis of the homeodomain transcription factor Chx10 in the retina using a novel multifunctional BAC transgenic mouse reporterDevelopmental Biology, 2004
- Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entryNature, 2003
- Vertebrate neural cell-fate determination: Lessons from the retinaNature Reviews Neuroscience, 2001
- Effects of an Rb mutation in the mouseNature, 1992
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences of the United States of America, 1971